Serotonin 5-HT1A receptors in brain regions of genetically predisposed to catalepsy rats

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 46, Issue 3, 1996, Pages 581-582

  Popova, N K ^a   Avgustinovich, D F ^a   Shigantsov, S N ^a   Kulikov, A V ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 1542741311     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Borsini F. Balance between cortical 5-HT1A and 5-HT2A receptor function; hypothesis for a faster antidepressant action//Pharmacol. Res. 1994. V. 10. No. 1. P. 1.
2. Broekkamp C. L., Berendsen H. H., Jenck F., Van Delft A. Animal models for anxiety and response to serotonergic drugs//Psychopathol. 1989. V. 22. Suppl. 1. P. 2.
3. Hammer R., Hori K., Blanchard R., Blanchard D. C. Domestication alters 5-HT1A receptor binding in rat brain//Pharmacol. Biochem. Behav. 1992. V. 42. P. 25.
4. Hicks P. B. The effect of serotonergic agents on haloperidolinduced catalepsy//Life Sci. 1990. V. 47. No. 18. P. 1609.
5. Humphrey P. P. A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors//TIPS. 1993. V. 14. P. 233.
6. Invernizzi R., Carli M., DiClemente A., Samanin R. Forebrain serotonin synthesis and release are regulated by serotonin 1A receptors in the nucleus raphe dorsalis//Serotonin from Cell Biology to Pharmacology and Therapeutics/Florence. 1989. P. 17.
7. Kidd E., Laporte A., Langlois X., et al. Differential localization and regulation of central 5-HT1A and 5-HT3 receptors//Serotonin CNS Receptors and Brain Function. Pergamon Press. 1992. P. 13.
8. Kolpakov V. G., Barykina N., Cherkasov I. Genetic predisposition to catatonic behavior and methylphenidate sensitivity in rats//Behav. Proc. 1981. V. 6. P. 269.
9. Kulikov A. V., Kozlachkova E. Y., Popova N. K. Activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats//Pharmacol. Biochem. Behav. 1992. V. 43. P. 999.
10. Kulikov A. V., Kolpakov V. G., Maslova G. B., et al. Effect of selective 5-HT1A agonists and 5HT2A antagonists on inherited catalepsy in rats//Psychopharmacol. 1994. V. 114. P. 172.
11. Lucas J., Hen R. New players in the 5-HT receptor field: genes and knockouts//TIPS. 1995. V. 16. N 7. P. 246.
12. Nikulina E. M., Popova N. K., Kolpakov V. G., Alekhina T. A. Brain dopaminergic system in rats with a genetic predisposition to catalepsy//Biogenic Amines. 1987. V. 4. No. 4-6. P. 399.
13. Nutt D. J., Glue P. Clinical pharmacology of anxiolytics and antidepressants: a psycopharmacological perspective//Psychopharmacology of Anxiolytics and Antidepressants/Ed. File S. E. N. Y.: Perg. Press. 1991. P. 1.
14. Peroutka S. J. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B and 5-HT1C binding sites in rat frontal cortex//J. Neurochem. 1986. V. 47. P. 529.
15. Popova N. K., Kulikov A. V. On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models//Am. J. Med. Genetics, Neuropsyhiatric Genetics. 1995. V. 60. No. 3. P. 214.
16. Rodgers R. J., Cole J., Davies A. Antianxiety and behavioral suppressant actions of the novel 5-HT1A receptor agonist, flesinoxan//Pharmacol. Biochem. Behav. 1994. V. 48. No. 3. P. 959.
17. Sharp T., Hjorth S. In vivo neurochemical studies of 5-HT1A autoreceptor function//Serotonin CNS Receptors and Brain Function/Eds. Bradley P. et al. Perg. Press. 1992. P. 297.